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Hyl-1 was first identified based on its homology with the yeast
ceramide synthase LAG1. Both HYL-1 and HYL-2 have been
shown to functionally complement LAG1 in a yeast ceramide
synthase knock-out strain and simultaneous deletion of both hyl-1
and hyl-2 entails lethality (1).
The C. elegans genome comprises three genes highly homologous
to the mammalian ceramide synthase LASS-4: hyl-1, hyl-2, and
lagr-1. Two functional domains characterize ceramide synthases,
the TLC domain and the Hox domain, however only the TLC
domain is required for synthase activity. The deduced protein
sequence shares a high level of identity among the C. elegans genes
and with the mammalian LASS-4 (left panel below). Each of the C.
elegans ceramide synthases contains a conserved TLC domain,
suggesting that they are all functional proteins.
Objective
The aim is to use C. elegans as a model organism to examine and
understand how alterations in ceramide and sphingolipid
metabolism affects signaling required for lipid homeostasis and
development.
Ceramides and sphingolipids are essential constituents of eukaryotic
cells and organisms. Besides playing structural roles in cellular
membranes, ceramide, sphingosine, and sphingosine-1-phosphate,
have drawn attention as bioactive signaling molecules involved in
regulation of cell growth, differentiation, senescence, and apoptosis,
and hence, have been associated with the development of a wide
range of diseases including obesity, insulin resistance, and cancers.
A delicate equilibrium between the levels of these interconvertible
sphingolipids underlies the balance between cell survival and
death. Ceramide consists of an N-acylated sphingoid long chain
base and is either produced by de novo synthesis or through the
hydrolysis of complex lipids, in particular sphingomyelin. The
action of ceramide synthase is to N-acylate the sphingoid long
chain base.
Median lifespans of N2 subjected to empty vector bacteria or
pha-4 RNAi are19 and 14 days, respectively.
Median lifespans of hyl-1;lagr-1 subjected to empty vector
bacteria or pha-4 RNAi are 23 and 15 days, respectively.
Subjected to empty vector control bacteria hyl-1;lagr-1 displays
a 21.1% extended lifespan compared to N2, P <0.0001.
Subjected to pha-4 RNAi, hyl-1;lagr-1 shows a 34.8% decrease
in lifespan compared to the hyl-1;lagr-1 control animals, P
<0.0001.
Subjected to pha-4 RNAi, N2 shows a 22.2% decrease in
lifespan when compared to N2 control animals , P <0.0001.
Comparing the hyl-1;lagr-1;pha-4(RNAi) animals with the pha-
4(RNAi) control animals shows a 7.1% extension in lifespan, P
= 0.24. Each treatment represents 360 animals (3 trials).
PHA-4/FOXA mediates lifespan
extension in hyl-1;lagr-1
hyl-1;lagr-1 exhibits dietary
restriction phenotypes
N2 hyl-1;lagr-1
AChRs are up-regulated in 
hyl-1;lagr-1
N2 hyl-1;lagr-1
α-Bungarotoxin is a
toxin used to stain
acetylcholine receptors.
By microinjecting the
toxin we were able to
visualize and quantify
the amount of
acetylcholine receptors
present at the pharyngeal
neuromuscular
junctions.
hyl-1;lagr-1 displays enhanced
synaptic transmission
Pumping rate is reduced
Compared to N2 which
displays a mean pumping
rate of 201 ± 2
pumps/min, hyl-1;lagr-1
shows a 17.4% decrease
with a mean pumping rate
of 166 ± 2, P <0.0001.
Ingestion rate of fluorescent beads is reduced
hyl-1;lagr-1 displays 59% less fluorescence indicating
a reduced feeding rate, P = 0.0026.
Brood size is reduced
Compared to N2 which
displays a mean brood
size of 304 ± 9,
hyl-1;lagr-1 shows a 33%
decrease with a mean
brood size of 204 ± 6,
P <0.0001.
Autophagy is increased
LGG-1 is part of 
autophagosomal 
membranes and widely 
used as an indicator of 
autophagy. Bars 
represent average 
number of LGG-1::GFP-
containing puncta per 
seem cell , P = 0.0012
hyl-1;lagr-1 displays a 115% increase in the amount
of α-Bungarotoxin staining at the pharyngeal
neuromuscular junctions , P = 0.02.
hyl-1;lagr-1 displays hypersensitivity to the acetylcholine
esterase inhibitor aldicarb.
Compared to N2, hyl-1;lagr-1 mutants are hypersensitive to
aldicarb, P < 0.0001 (n = 100, 4 trials) .
Knock-down of PHA-4 increases aldicarb resistance in wild
type but has no effect on hyl-1;lagr-1 hypersensitivity
Subjected to the empty vector bacteria hyl-1;lagr-1 displays
hypersensitivity to aldicarb compared to N2, P < 0.0001.
Subjected to pha-4 RNAi hyl-1;lagr-1 shows no difference in
aldicarb sensitivity compared to the hyl-1;lagr-1 control
animals, P = 0.6633.
N2 subjected to pha-4 RNAi shows a small increase in
sensitivity to aldicarb compared to N2 control animals, P =
0.0040.
Compared to N2 subjected to pha-4 RNAi, hyl-1;lagr-1
subjected to pha-4 RNAi shows increased sensitivity to
aldicarb, P < 0.0001.
Each treatment represents 50 animals (2 trials).
In the present work we show that functional loss of HYL-1
and LAGR-1 elicits a PHA-4 mediated lifespan extension
which is accompanied by phenotypes characteristic of
dietary restriction-induced longevity as well as enhanced
synaptic transmission.
We show that functional loss of HYL-1 and LAGR-1 results in:
• Increased lifespan mediated by PHA-4
• Reduced feeding and pumping rate
• Reduced brood size
• Increased autophagy
• Increased number of AChRs at the pharyngeal NMJ
• PHA-4 independent hypersensitivity towards aldicarb
• Hypersensitivity towards levamisole
The present work indicates that hyl-1;lagr-1 longevity is due
to a starvation response mediated by PHA-4.
We are currently examining the molecular links between
the aging phenotype and the observed aldicarb
hypersensitivity and how changes in ceramide levels convey
these phenotypes.
hyl-1;lagr-1 displays hypersensitivity to the acetylcholine
antagonist levamisole.
Compared to N2, hyl-1;lagr-1 mutants are hypersensitive to
levamisole, P < 0.0001 (n = 75, 3 trials).
